BNET Industries
Last Fiscal Year Sales:$45.0M
- Public
- US
Dow Jones Description
Zila, Inc., headquartered in Phoenix, Arizona, is a diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. In this report, Zila, the Company, we, us, or our refers to Zila, Inc. and its wholly-owned subsidiaries. Zila, Inc. is a holding company that conducted its business operations during fiscal 2008 through its wholly-owned subsidiaries: Zila Pharmaceuticals, Inc., Professional Dental Technologies, Inc. (Pro-Dentec), Zila Biotechnology, Inc., Zila Technical, Inc., Zila Limited (a United Kingdom company) and Ryker Dental of Kentucky, Inc. (inactive). We manufacture and market ViziLite ® Plus with TBlue ® (ViziLite ® Plus), our flagship product for the early detection of oral abnormalities that could lead to cancer. ViziLite ® Plus is an adjunctive medical device cleared by the FDA for use in a population at increased risk for oral cancer. In addition, Zila designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rotadent ® Professional Powered Brush, the Pro-Select Platinum ® ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use. All of our products are marketed and sold in the United States and Canada primarily through our direct field sales force and telemarketing organization. ...
CFO & Vice President
Andrew A. StevensNumber of Employees 367
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Zila Merger Agreement with Tolmar Amended to Reflect Higher Stock Price
-
Tampa dental firm Intelident launches bidding war for Zila
-
Intelident Solutions Reaffirms Proposal to Acquire Zila
-
Zila, Tolmar ink merger deal
-
Zila Board Finds the Intelident Proposal Not Superior to Tolmar Offer
-
Zila Releases Fiscal 2009 3Q Financial Results
News & Analysis
Filter by
zila inc. - All News and Analysis
Zila Inc F1Q09 (Qtr End 11/01/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Harvey Cappitski - Maloney Securities. Harvey Cappitski - Maloney Securities Why do you think your lenders are not being well cooperative with you? I mean you seem to have been successful in the past, you seem to know what...
Zila Requests NASDAQ Investigation
PHOENIX -- Zila, Inc. (Nasdaq:ZILAD) today announced that, as a result of suspicious end-of-day trading in the Company's stock during the past several weeks, the Company has made an urgent request that NASDAQ undertake an investigation to determine the reasons for this activity. About Zila, Inc. Zila, Inc.,...
Zila, Inc. F4Q08 (Qtr End 07/31/08) Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of Marc Robins - The Robins Group Marc Robins - The Robins Group Let’s talk about the Arizona facility there in Phoenix, any thought of closing that down and moving things to Arkansas? David Bethune ...
Zila, Inc. F3Q08 (Qtr End 04/30/2008) Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Your first question comes from Neal Goldman - Goldman Capital Management. Neal Goldman - Goldman Capital Management Do you believe that you have sufficient capital on hand that you won’t need to refinance further until you achieve cash flow breakeven? David...
Zila, Inc. F1Q08 (Qtr End 10/31/07) Earnings Call Transcript
Question-and-Answer SessionOperator Thank you sir. We will now begin the question and answer session. As a reminder, if you have a question please press the star followed by the one on your touchtone phone. If you would like to withdraw a question, press star followed by...
Zila to Restate Financial Results
Business Editors, Health/Medical Writers PHOENIX--BUSINESS WIRE--Oct. 24, 2002 Zila, Inc. (Nasdaq:ZILA) today announced that it will restate its financial results for previous fiscal periods in response to requests and comments from the U.S. Securities and Exchange Commission SEC on its accounting for certain transactions. The restatements will...
Zila Rebuilding Advances With New Division Leaders — John L. Maverick, VP & GM, Zila Pharmaceuticals, Ronald L. Fugate, VP & GM, Zila Nutraceuticals
Business Editors, Health/Medical Writers PHOENIX--BUSINESS WIRE--Sept. 18, 2002 Doug Burkett, Ph.D., President and Chief Executive Officer of Zila, Inc. (Nasdaq:ZILA), announced that John L. Maverick has been named Vice President and General Manager of Zila Pharmaceuticals, and Ronald L. Fugate has been named Vice President and General Manager...
MEDE AMERICA to Handle All Electronic Claims Processing for PracticeWorks
EAST MEADOW, N.Y.--BW HealthWire--March 25, 1999--MEDE AMERICA (Nasdaq: MEDE), a leading provider of integrated EDI Solutions to the healthcare industry, today announced an exclusive agreement with PracticeWorks to handle all of the company's electronic claims processing. PracticeWorks, a division of Zila Inc. (Nasdaq: ZILA), is one of the largest practice...
Wechsler Harwood Files Class Action Against Zila, Inc
NEW YORK--BUSINESS WIRE--March 8, 1999--Notice is hereby given that on February 4, 1999 a class action lawsuit was filed in the United States District Court for the District of Arizona against Zila, Inc. ("Zila") (Nasdaq:ZILA) and certain of its officers and directors for violations of Sections 10b and 20a of...
Wechsler Harwood Files Class Action Against Zila, Inc
NEW YORK--BUSINESS WIRE--March 2, 1999--The following is announcement by the law firm of Wechsler Harwood Halebian & Feffer LLP: Notice is hereby given that on February 4, 1999 a class action lawsuit was filed in the United States District Court for the District of Arizona against Zila, Inc. ("Zila")...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew A. Stevens | CFO & Vice President |
| Frank J. Bellizzi | Executive Vice President, Business Development |
| Betty Pecha | Vice President, Legal |
| Diane E Klein | Vice President and Treasurer |
| G. Warren Chane | Vice President, Corp Business Development |
| Gary V. Klinefelter | Vice President and General Counsel |
| George Heiler | Vice President, Manufacturing Operations |
| David A Barshis | Senior Vice President, General Manager, Zila Pharma |
| Charles Shively | Director, Product Development |
| Yu Ping Maguire | Head, Clinical & Regulatory Affairs |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| David R. Bethune | Chairman |
| Christopher D. Johnson | Board of Directors |
| George J Vuturo | Board of Directors |
| J Steven Garrett | Board of Directors |
| Jon M. Plexico | Board of Directors |
| Leslie Green | Board of Directors |
| O.B. Parrish | Board of Directors |
| Wade F Brooksby | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | CFO & Vice President | Current |
| Arnall Golden & Gregory, Llp | Current | |
| AMERCO | Chief Financial Officer | Former |
| CSK Auto Inc. | Vice President, Finance and Controller | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Executive Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Legal | Current |
Vice President and Treasurer since June 2004. Ms. Klein joined ZILA in August 2003 as Director of Finance. Ms. Klein was Vice President-Finance for Bay Area Foods, Inc., a privately held grocery chain, from 1998 to 2003. Prior to Bay Area Foods, Ms. Klein held progressively responsible financial/accounting positions at Southwest Supermarkets, LLC, MegaFoods Stores, Inc. and the Circle K Corporation. She was previously a senior manager in the audit practice of Arthur Andersen & Co. in Phoenix, AZ.
| Organization | Position | Status |
|---|---|---|
| Ce Space, LLC | Vice President and Treasurer | Current |
| Zila, Inc. | Vice President and Treasurer | Current |
| Zila, Inc. | Director of Finance | Current |
| Ce Space, LLC | Director of Finance | Former |
| Circle K | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Corp Business Development | Current |
Gary Klinefelter has served as Zila’s Vice President and General Counsel since December 2004. Mr. Klinefelter was appointed Zila’s Secretary in October 2005. From 1988-2004, he was Secretary and General Counsel of AMERCO, a holding company whose principal operating subsidiaries are U-Haul International, Inc., Republic Western Insurance Company and Oxford Life Insurance Company. Mr. Klinefelter is licensed as an attorney in Arizona.
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President and General Counsel | Current |
| Professional Dental Technologies, Inc. | Vice President and General Counsel | Current |
| Arnall Golden & Gregory, Llp | Current | |
| Republic Western Insurance Company | Principal | Former |
| Oxford Life Insurance Company | Principal | Former |
| AMERCO | Secretary and General Counsel | Former |
| U-Haul International, Inc. | Principal | Former |
| AMERCO | Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Manufacturing Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Senior Vice President, General Manager, Zila Pharma | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Director, Product Development | Current |
| Zila, Inc. | Director, Product Development | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Head, Clinical & Regulatory Affairs | Current |
Mr. Bethune has served as our Executive Chairman since August 2007. He has been a member of the board since 2005 and was appointed chairman on May 21, 2007. He is also a member of the Board of Cambrex Corporation. From 1999 until his retirement, he was Chairman and Chief Executive Officer of Atrix Laboratories, a drug delivery and product development company. Prior to Atrix Laboratories, he was President and Chief Operating Officer of IVAX Corporation, a pharmaceutical company. Before joining IVAX, Mr. Bethune began a start-up pharmaceutical company venture formed by Mayo Medical Ventures, a business unit of Mayo Clinics of Rochester. Mr. Bethune previously served as group vice president of American Cyanamid Company and a member of the Executive Committee where he had executive authority for human biologicals, consumer health products, pharmaceuticals and ophthalmics as well as global medical research. He was also President of the Lederle Laboratories Division of American Cyanamid Company. Mr. Bethune received a B.A. degree in accounting and economics from Lenior-Rhyne College, Hickory, North Carolina and Masters in Business Administration in the Executive Program from Columbia University Graduate School.
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Interim Chief Executive Officer | Current |
| Arnall Golden & Gregory, Llp | Current | |
| Zila, Inc. | Chairman | Current |
| Cambrex Corporation | Board of Directors | Current |
| The Female Health Company | Board of Directors | Current |
| Zila, Inc. | Board of Directors | Current |
| The Female Health Company | Chairman & CEO | Former |
| American Cyanamid Company | President | Former |
| IVAX Corporation | Chief Operating Officer | Former |
| American Cyanamid Company | Group Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| QLT, Inc. | Board of Directors | Former |
| University of Florida | Ph.D. In Health Care Administration | Former |
| Fairfield University | B.S. In Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Tolmar Inc. | Vice President of Clinical Development | Current |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| Zila, Inc. | Board of Directors | Current |
| Loma Linda University | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| Merriman Curhan Ford & Co. | Vice President, Healthcare | Former |
| Merriman Curhan Ford & Co. | Managing Director, Healthcare | Former |
| Quidel Corporation | National Sales Manager, Autoimmune & Complement Division | Former |
| Colgate University | B.A., Political Science | Former |
| Organization | Position | Status |
|---|---|---|
| Green Inc. | Managing Partner | Current |
| Roffe & Green, Inc | Current | |
| Arnall Golden & Gregory, Llp | Current | |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| Zila, Inc. | Board of Directors | Current |
| Ssoe, Inc. | Board of Directors | Current |
| Nydic | Chief Executive Officer | Former |
| Nydic | President | Former |
| Swiss Army Brands, Inc. | Vice President, New Business Development and Strategic Planning | Former |
| Zila, Inc. | General Manager and interim National Sales Manager | Former |
| American Home Products Corporation | Marketing Manager | Former |
| Zila, Inc. | Interim National Sales Manager | Former |
| Marine Midland Bank | Marketing Manager | Former |
| Citicorp | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| The Female Health Company | Chairman & CEO | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes


